Form D Explorer

Source evidence

Linnaeus Therapeutics, Inc. · 0001752026-26-000008

D filed Nov. 18, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
HADDONFIELD
street1
30 WASHINGTON AVENUE, SUITE F
zipCode
08033
entityName
Linnaeus Therapeutics, Inc.
entityType
Corporation
stateOrCountry
New Jersey
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold3734103number3734103/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount10000000number10000000/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment1number1/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count4number4/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: f2508748c241f11f5afdd0ea2c99b12b8bf01160a49840f953a041e991860086. This proves extraction identity, not the accuracy of the filer's claims.